May 29, 2020

The Niche

Knoepfler lab stem cell blog

CRAGMOONT CAPITAL LLC

2 min read

It’s difficult to make it as a biotech company and I would say stem cell biotechs in general may have an even rougher time. One such company,  Intellicell (Intellicell Biosciences, Inc), is showing a number of signs of distress in my opinion. An online financial tool predicts the probability of companies going bankrupt within the next 24 months. For Intellicell it estimates a greater than 96% chance of bankruptcy. By comparison another stem cell biotech, Stem Cells Inc., has a less than 1% change of going bankrupt. How accurate are …Read More